We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Zika Virus IgM Antibody Found in West Nile Virus Patients

By LabMedica International staff writers
Posted on 05 Oct 2021
Print article
Image: The Zika IgM antibody-capture, enzyme-linked immunosorbent assay (Zika MAC-ELISA) for antibody testing (Photo courtesy of the Centers for Diseases Control and Prevention).
Image: The Zika IgM antibody-capture, enzyme-linked immunosorbent assay (Zika MAC-ELISA) for antibody testing (Photo courtesy of the Centers for Diseases Control and Prevention).
West Nile virus (WNV) and Zika virus (ZIKV) are mosquito-borne viruses in the family Flaviviridae. Residents in, and travelers to, areas where the viruses are circulating are at risk for infection, and both viruses can cause an acute febrile illness.

In the contiguous USA, WNV disease is the most commonly reported arboviral disease, with about 2,000 to 6,000 reported cases each year. WNV disease presentations range from mild febrile illness to severe neuroinvasive disease. Almost all ZIKV disease cases in the continental USA are travel associated.

Vector Borne Disease experts at the Centers for Diseases Control and Prevention (CDC, Fort Collins, CO, USA) included serum samples from 153 persons with confirmed recent WNV infection in their analysis. The median age of patients was 59 years (range 10–92 years) and 53 (35%) were female. Samples were collected at a median of seven days (range 0–40 days) after symptom onset. Serum samples were tested for the presence of ZIKV IgM antibody with CDC's envelope protein antigen-based ZIKV IgM antibody capture-ELISA (Zika MAC-ELISA). A P/N value <2.0 was interpreted as negative, a P/N from 2.0 to <3.0 was equivocal, and a P/N ≥ 3.0 was positive.

The scientists reported that among 153 sera from patients with acute WNV infection, the ZIKV IgM antibody result was positive in 56 (37%; 95% confidence interval [CI] 29–44%) and equivocal in 28 (18%; 95% CI 13–25%). With 55% of samples having cross-reactive antibodies, it is important for health care providers to request appropriate testing based on the most likely cause of a patient's possible arboviral infection considering their clinical symptoms and signs, travel history, and place of residence. Patients were significantly more likely to have a ZIKV IgM antibody-positive or equivocal result if their sample had both WNV and St. Louis encephalitis virus (SLEV)-neutralizing antibodies, compared with patients with samples with only WNV-neutralizing antibodies (relative risk = 2.1), and this association was not modified by nor required adjustment for sex.

The authors concluded that for cases where the epidemiology does not support the preliminary IgM findings, confirmatory neutralizing antibody testing should be performed. These measures will avoid an incorrect diagnosis of ZIKV infection, based on cross-reactive antibodies, in a person truly infected with WNV. The study was published on July 22, 2021 in the journal Vector-Borne and Zoonotic Diseases.

Related Links:
Centers for Diseases Control and Prevention

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.